CoNi alloy nanoparticles for cancer theranostics: synthesis, physical characterization, in vitro and in vivo studies

Abstract

Nanomaterials are attracting increasing interest in many biomedical fields, including the fight against cancer. In this context, we successfully synthesized CoNi alloy nanoparticles (NPs) by a simple polyol process. The magnetic characteristics of the products were measured by vibration sample magnometry, which revealed that the samples have soft ferromagnetic behavior. The microstructure and morphology were inspected by X-ray diffraction and scanning electron microscopy, respectively. Human cancer cells derived from the breast (MCF7) and oral cavity (C152) and normal cells derived from human umbilical vein endothelial cells (HUVECs) were treated with increasing concentrations of CoNi NPs, and their cytotoxic effect was measured via MTT and lactate dehydrogenase (LDH) leakage assays. We found that treatments by using 12.5 to 400 µg/mL of Co0.5Ni0.5, Co0.6Ni0.4, and Co0.4Ni0.6 NPs were associated with significant concentration-dependent toxicity toward such cell lines and profoundly enhanced LDH leakage following 48 h of exposure (P < 0.05 compared with untreated cells). Besides, a NP dose of 6.25 µg/mL did not affect the survival of HUVECs while leading to marked cell death in MCF7 and C152 cells. In vivo experiments in rats were done to investigate the biochemical and histopathological changes over three weeks, following intraperitoneal administration of Co0.5Ni0.5, Co0.6Ni0.4, and Co0.4Ni0.6 NPs (100 mg/kg). As compared with the controls, the exposure to NPs caused significant elevations in aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, serum creatinine, serum catalase activity, serum superoxide dismutase, and liver malondialdehyde levels. Also, rats treated with Co0.6Ni0.4 NPs showed more severe histopathological changes of the liver and kidney. Our findings represent an essential step toward developing theranostic nanoplatforms for selective cancer treatment.

Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements

“…Multipurpose nanotechnology-based plans with diagnostic imaging and targeted treatment roles have been among the most debated topics in the nanomedical research field [ 69 , 70 , 71 , 72 , 73 ]. Lately, much effort has been put into developing novel nano-based systems for theranostic purposes against BC.…”

Laser Synthesized Core-Satellite Fe-Au Nanoparticles for Multimodal In Vivo Imaging and In Vitro Photothermal Therapy

“…Magnetic nanoparticles (NPs) consisting of iron, gadolinium, manganese, and other metals are widely studied for biomedical applications, e.g., drug delivery, magnetic resonance imaging (MRI), or visualization with magnetic spectral approaches [ 1 , 2 , 3 , 4 ]. However, independently of doping metals (Mn, Co, and Ni), most magnetic NPs are iron oxide based.…”

A novel dual MoS2/FeGA quantum dots endowed injectable hydrogel for efficient photothermal and boosting chemodynamic therapy

“…Traditional tumour treatment approaches including surgery, chemotherapy and radiation each have their own set of issues such as multidrug resistance, poor patient status after surgery and so on ( Chang et al, 2020 ; Liu et al, 2020 ; Liu et al, 2021a ). The development of nanotechnology has opened up new opportunities for the cancer treatment ( Xie et al, 2019 ; Yang et al, 2020 ; Almanghadim et al, 2021 ; Sargazi et al, 2021 ). Targeting specific tumour microenvironments (weak acidity, hypoxia, high content of hydrogen peroxide (H 2 O 2 )) with diverse nano systems can effectively remove malignancies ( Zhu et al, 2022a ).…”